手术资格不等于手术公平:I/II期胰头腺癌根治性治疗推荐随年龄和种族而异
该研究基于美国国家癌症数据库分析40-89岁、合并症指数0-1的I/II期胰头腺癌患者,比较不同年龄和种族间胰腺切除术推荐率的差异。共纳入40866例患者,其中非西班牙裔白人36133例(88%),非西班牙裔黑人4733例(12%)。结果显示非西班牙裔黑人患者的胰腺切除术推荐等效点(PREP)比白人年轻5岁(75岁 vs 80岁),且各年龄组中黑人患者未获手术推荐的调整率显著更高;调整手术推荐后,两组总生存无差异(HR 0.98,95%CI 0.94-1.02)。
要点
- 手术资格不等于手术公平,年龄和种族差异影响胰腺切除术推荐。
- 非西班牙裔黑人患者PREP比白人年轻5岁(75岁 vs 80岁)。
- 各年龄组黑人患者未获手术推荐的调整率均显著更高。
核心结论
- 非西班牙裔黑人患者的胰腺切除术推荐等效点(PREP)比白人患者年轻5岁,且各年龄组未推荐手术的调整率均更高。
- 年龄和种族在治疗推荐上的差异可能贡献于非西班牙裔黑人患者较短的生存期。
研究设计与样本
- 基于美国国家癌症数据库的回顾性队列研究,纳入临床I/II期胰头腺癌、Charlson合并症指数0-1、年龄40-89岁的非西班牙裔白人和非西班牙裔黑人患者。
- 共纳入40866例患者,其中非西班牙裔白人36133例(88%),非西班牙裔黑人4733例(12%)。
主要发现
- 整个队列的PREP为79岁;非西班牙裔黑人患者PREP为75岁,非西班牙裔白人为80岁。
- 各年龄组中,非西班牙裔黑人患者未获手术推荐的调整率显著高于非西班牙裔白人患者。
- 调整手术推荐后,非西班牙裔白人与非西班牙裔黑人患者的总生存无差异(HR 0.98,95%CI 0.94-1.02)。
临床怎么用
- 临床医生在评估I/II期胰头腺癌患者的手术推荐时,应警惕年龄和种族可能带来的推荐差异。
- 对于非西班牙裔黑人患者,尤其需要审视是否因非临床因素导致手术推荐不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to characterize differences in pancreatectomy recommendation rates to surgically eligible patients with pancreatic ductal adenocarcinoma of the pancreatic head across age and racial groups. BACKGROUND: Pancreatectomy is not recommended in almost half of otherwise healthy patients with stage I/II pancreatic ductal adenocarcinoma lacking a surgical contraindication. We characterized differences in pancreatectomy recommendation among surgically eligible patients across age and racial groups. METHODS: Non-Hispanic White (NHW) and Non-Hispanic Black (NHB) patients were identified in the National Cancer Database with clinical stage I/II pancreatic head adenocarcinoma, Charlson Comorbidity Index of 0 to 1, and age 40 to 89 years. Rates of surgery recommendation and overall survival (OS) by age and race were compared. A Pancreatectomy Recommendation Equivalence Point (PREP) was defined as the age at which the rate of not recommending surgery matched the rate of recommending and completing surgery. Marginal standardization was used to identify association of age and race with recommendation. OS was compared using Kaplan-Meier and Cox regression models. RESULTS: Among 40,866 patients, 36,133 (88%) were NHW and 4733 (12%) were NHB. For the entire cohort, PREP was 79 years. PREP was 5 years younger in NHB patients than in NHW patients (75 vs 80 years). Adjusted rates of not recommending surgery were significantly higher for NHB than for NHW patients in each age group. After adjusting for surgery recommendation, we found no difference in OS between NHW and NHB patients (hazard ratio 0.98 [95% CI 0.94-1.02]). CONCLUSIONS: PREP of NHB patients was 5 years younger than NHW patients, and in every age group, the rate of not recommending pancreatectomy was higher in NHB patients. Age and race disparities in treatment recommendations may contribute to shorter longevity of NHB patients.
引用
- Hester CA, Kothari AN, Mason M, et al. Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race. Ann Surg. 2023. PMID: 34183508. doi:10.1097/SLA.0000000000005033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。